Compare Enphase Energy Inc (ENPH) vs Repligen Corporation Common Stock (RGEN) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Enphase Energy Inc vs Repligen Corporation Common Stock — how do they compare? Enphase Energy Inc trades at $28.76 (market cap $4.23B), while Repligen Corporation Common Stock trades at $178.85 (market cap $11.31B). The key difference: Repligen Corporation Common Stock is far larger — about 2.7× Enphase Energy Inc's market cap, and Repligen Corporation Common Stock is trading nearer its 52-week high, Enphase Energy Inc nearer its low. Which is the better fit depends on your goals — on Pluang, investors hold Enphase Energy Inc for 72 Days and Repligen Corporation Common Stock for 0 Days on average.
| ENPH | RGEN | |
|---|---|---|
Market Cap | $4.23B | $11.31B |
Volume | 4,755,897 | 1,216,919 |
Sector | Energy | Health |
52-Week High | $72.33 | $194.57 |
52-Week Low | $26.12 | $102.87 |
Typical Hold Time | 72 Days | 0 Days |
Enterprise Value | $3.88B | $11.20B |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Enphase Energy (ENPH) trades at $32.03, up 1.71% on the day, but remains in a technical downtrend with a bearish moving average signal. The stock faces pressure from recent earnings misses in Q1 and Q2 2026, though it beat expectations in Q4 2025. Revenue declined from $2.3B in 2023 to $1.47B in 2025, but net income margin improved to 11.68%. Recent news highlights product approvals and expansion into AI data center power solutions, providing potential growth catalysts amid a challenging solar sector environment.
The outlook is mixed; analyst consensus is a Buy with a $42.68 price target, implying significant upside, but high borrowing costs and solar industry headwinds pose risks. The stock's current valuation at a P/E of 31.71 may limit near-term gains if earnings growth stalls. Investors should weigh the company's innovation in smart energy solutions against macroeconomic pressures and competitive dynamics in the renewable energy market.
RGEN trades at $175.42, up 1.66% today, with a neutral technical signal and key support at $173. The stock has consistently beaten earnings estimates in recent quarters, with Q3 2026 results due October 27. Revenue grew to $738.26M in 2025, though net income margin is modest at 5.29%. The company recently completed the acquisition of BioLife Solutions, signaling strategic expansion.
Outlook remains positive with strong analyst support (91.67% buy ratings) and a consensus price target of $173.86, though high valuation multiples (P/E 240.34) pose a risk. Earnings growth and integration of acquisitions are key catalysts, but investors face execution risks and market volatility.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Enphase Energy Inc
Enphase Energy is a global energy technology company. The company delivers smart, easy-to-use solutions that manage solar generation, storage, and communication on one platform. The company's microinverter technology primarily serves the rooftop solar market and produces a fully integrated solar-plus-storage solution. Geographically, it derives a majority of revenue from the United States.
Read more on ENPH →About Repligen Corporation Common Stock
Repligen Corporation develops and manufactures bioprocessing tools and technologies used in biologic drug manufacturing, including filtration and perfusion systems, chromatography columns and resins, and process analytics instruments. Its products support upstream and downstream production workflows for modalities such as monoclonal antibodies, mRNA, and viral vectors.
Read more on RGEN →
